Safety of mRNA vaccines administered during the initial 6 months of the US COVID-19 vaccination programme: an observational study of reports to the Vaccine Adverse Event Reporting System and v-safe

Hannah G. Rosenblum, Julianne Gee, Ruiling Liu, Paige Marquez, Bicheng Zhang, Penelope Strid, Winston E. Abara, Michael M. McNeil, Tanya R. Myers, Anne M. Hause, John R. Su, Lauri E. Markowitz, Tom T. Shimabukuro, David K. Shay